Human dnase i hyperactive variants
AssigneeGenentech, Inc.
InventorsRobert A. Lazarus, Clark Qun Pan
Life of this patent
Estimating the term…
Abstract
The present invention relates to amino acid sequence variants of human DNase I that have increased DNA-hydrolytic activity. The invention provides nucleic acid sequences encoding such hyperactive variants, thereby enabling the production of these variants in quantities sufficient for clinical use. The invention also relates to pharmaceutical compositions and therapeutic uses of hyperactive variants of human DNase I.
Claims12
A human DNase I hyperactive variant.
A human DNase I hyperactive variant having an amino acid sequence that differs from the amino acid sequence shown in FIG. 1 by the substitution of one amino acid for another at two or more positions within the FIG. 1 sequence.
An isolated nucleic acid encoding a human DNase I hyperactive variant.
Dependencies are inferred from the claim text.